You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Downstaging

Showing 1 - 25 of 273
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Shanghai (PD-1 and Lenvatinib Plus TACE)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1 and Lenvatinib Plus TACE
  • Shanghai, Shanghai, China
    Huashan hospital
Aug 16, 2022

HCC Trial in Hong Kong (procedure, radiation, drug)

Active, not recruiting
  • HCC
  • TACE
  • +2 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Oct 24, 2022

Non Small Cell Lung Cancer Trial (Osimertinib Mesylate)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Osimertinib Mesylate
  • (no location specified)
May 18, 2022

HCC Trial in Hong Kong (procedure, radiation, drug)

Recruiting
  • HCC
  • TACE
  • +3 more
  • Hong Kong, Hong Kong
  • +1 more
Jul 23, 2021

Carcinoma, Hepatocellular, Cirrhosis Trial in Italy (Liver transplantation)

Completed
  • Carcinoma, Hepatocellular
  • Cirrhosis
  • Liver transplantation
  • Bergamo, Italy
  • +9 more
Oct 4, 2021

Aggressive Hepatocellular Carcinomas Treated Using SIRT

Completed
  • Hepatocellular Carcinoma
    • Montpellier, France
      Uhmontpellier
    Sep 29, 2021

    Hepatocellular Carcinoma Trial in Beijing (procedure, device, drug)

    Recruiting
    • Hepatocellular Carcinoma
    • DEB-TACE
    • +3 more
    • Beijing, China
      Beijing Tsinghua Chang Gung Hospital
    Feb 3, 2021

    Prostate Cancer Trial in Beijing (Darolutamide+ADT)

    Not yet recruiting
    • Prostate Cancer
    • Beijing, China
      Peking University First Hospital
    Sep 1, 2023

    The ImmunoXXL Study

    Recruiting
    • Hepatocellular Carcinoma
    • Liver Transplantation
    • Milano, MI, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    May 25, 2023

    Locally Advanced, Squamous Cell Carcinoma of the Vulva Trial in Amsterdam (Paclitaxel and Carboplatin)

    Recruiting
    • Locally Advanced, Squamous Cell Carcinoma of the Vulva
    • Paclitaxel and Carboplatin
    • Amsterdam, Netherlands
      NKI-AVL
    Oct 18, 2022

    Rectal Cancer Trial in Krakow (Preoperative radiotherapy, Surgery)

    Completed
    • Rectal Cancer
    • Preoperative radiotherapy
    • Surgery
    • Krakow, Malopolska, Poland
      1st Department of General Surgery
    Jul 10, 2022

    High-grade Salivary Gland Carcinoma Trial in Seoul (nivolumab, docetaxel, cisplatin Group)

    Recruiting
    • High-grade Salivary Gland Carcinoma
    • nivolumab, docetaxel, cisplatin Group
    • Seoul, Korea, Republic of
      Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
    Feb 3, 2023

    Hyperthermia, Radiotherapy Trial (Deep Hyperthermia)

    Not yet recruiting
    • Hyperthermia
    • Radiotherapy
    • Deep Hyperthermia
    • (no location specified)
    Sep 27, 2021

    Hepatocellular Carcinoma, Liver Transplant Trial in Hangzhou (Camrelizumab plus apatinib)

    Unknown status
    • Hepatocellular Carcinoma
    • Liver Transplant
    • Camrelizumab plus apatinib
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Medical School of Zhejiang Univ
    Jul 26, 2019

    Hepatocellular Carcinoma Trial (Donafenib, TACE)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • (no location specified)
    Oct 8, 2022

    Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy

    Recruiting
    • Muscle-Invasive Bladder Carcinoma
    • +2 more
    • cisplatin based neoadjuvant chemotherapy
    • Radical cystectomy alone
    • Rome, Italy
      Riccardo Mastroianni
    Mar 8, 2023

    Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)

    Not yet recruiting
    • Adenocarcinoma - GEJ
    • Gastric Adenocarcinoma
    • (no location specified)
    Sep 26, 2023

    Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for

    Recruiting
    • Hepatocellular Carcinoma Non-resectable
    • HAIC
    • +8 more
    • Quanzhou, Fujian, China
    • +1 more
    Jan 26, 2023

    Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for

    Recruiting
    • Hepatocellular Carcinoma Non-resectable
    • TACE
    • +8 more
    • Quanzhou, Fujian, China
    • +3 more
    Jan 29, 2023

    Carcinoma, Renal Cell Trial in New York (Spartalizumab, Canakinumab)

    Recruiting
    • Carcinoma, Renal Cell
    • New York, New York
      Columbia University Medical Center
    May 6, 2022

    Esophageal Squamous Cell Carcinoma Trial in Anyang, Zhengzhou (AK104, nab-paclitaxel, carboplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • AK104, nab-paclitaxel, carboplatin
    • Anyang, Henan, China
    • +1 more
    Jun 1, 2023

    Rectal Cancer Trial in Alexandria (radiation, drug, procedure)

    Completed
    • Rectal Cancer
    • Radiotherapy
    • +2 more
    • Alexandria, Egypt
      Ahmed Samir Ashoor
    Mar 7, 2022

    Bladder Cancer Trial in Chapel Hill, Durham (pembrolizumab, gemcitabine and cisplatin)

    Active, not recruiting
    Has Results
    • Bladder Cancer
    • pembrolizumab, gemcitabine and cisplatin
    • Chapel Hill, North Carolina
    • +1 more
    Oct 11, 2022

    Pancreatic Cancer Trial in Tianjin (surufatinib + gemcitabine + nab-paclitaxel)

    Recruiting
    • Pancreatic Cancer
    • surufatinib + gemcitabine + nab-paclitaxel
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jun 15, 2023

    NSCLC Trial (JDQ443)

    Not yet recruiting
    • NSCLC
    • (no location specified)
    Feb 2, 2023